4th Quarter - Report

TCH GROUP, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General heath care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative regulatory issues. Drug Safety Issues. 340 B policy issues. Importation policy issues.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3590 (113th)

Medicare/Medicaid MMM

Medicare Part D issues. H.R. 928 Medicare Prescription Drug Savings and Choice Act of 2013: Provisions related to patent issues. Medicare Drug Savings Act: Part D Issues S. 117 Medicare Prescription Drug Price Negotiation Act of 2013. S. 351 Protecting Seniors Access to Medicare Act of 2013 S. 408 Medicare Prescription Drug Saving and Choice Act of 2013. 340B Drug Program Issues related to changes to the Medicare Part B reimbursement of perscription drugs; issues related to coverage and reimbursementfor those who are covered by the Medicaid program and the Medicare program, including the Part D prescription drug benefit; and general issues related to the Medicare Part D program.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 117 (113th), H.R. 928 (113th), S. 408 (113th), S. 351 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.